Terms: = Skin cancer AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150 AND Treatment
7 results:
1. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
[TBL] [Abstract] [Full Text] [Related]
2. [treatment of distal tibial tumor with vascularized fibula reconstruction].
Li X; Teng X; Lin N; Yan X; Li B; Ye Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Oct; 34(10):1221-1225. PubMed ID: 33063483
[TBL] [Abstract] [Full Text] [Related]
3. International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.
Sperr WR; Kundi M; Alvarez-Twose I; van Anrooij B; Oude Elberink JNG; Gorska A; Niedoszytko M; Gleixner KV; Hadzijusufovic E; Zanotti R; Bonadonna P; Bonifacio M; Perkins C; Illerhaus A; Elena C; Merante S; Shoumariyeh K; von Bubnoff N; Parente R; Jawhar M; Belloni Fortina A; Caroppo F; Brockow K; Zink A; Fuchs D; Kilbertus AJ; Yavuz AS; Doubek M; Hägglund H; Panse J; Sabato V; Bretterklieber A; Niederwieser D; Breynaert C; Hartmann K; Triggiani M; Nedoszytko B; Reiter A; Orfao A; Hermine O; Gotlib J; Arock M; Kluin-Nelemans HC; Valent P
Lancet Haematol; 2019 Dec; 6(12):e638-e649. PubMed ID: 31676322
[TBL] [Abstract] [Full Text] [Related]
4. Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry.
Mease PJ; Etzel CJ; Huster WJ; Muram TM; Armstrong AW; Lisse JR; Rebello S; Dodge R; Murage MJ; Greenberg JD; Malatestinic WN
RMD Open; 2019; 5(1):e000867. PubMed ID: 31245045
[TBL] [Abstract] [Full Text] [Related]
5. Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients.
Zhang K; Sun X; Xie F; Jian W; Li C
J Cancer Res Ther; 2018 Jan; 14(1):196-200. PubMed ID: 29516985
[TBL] [Abstract] [Full Text] [Related]
6. Temporal Trends in treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood cancer, 1970-2015.
Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
[TBL] [Abstract] [Full Text] [Related]
7. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.
Kurtzberg J; Prockop S; Teira P; Bittencourt H; Lewis V; Chan KW; Horn B; Yu L; Talano JA; Nemecek E; Mills CR; Chaudhury S
Biol Blood Marrow Transplant; 2014 Feb; 20(2):229-35. PubMed ID: 24216185
[TBL] [Abstract] [Full Text] [Related]
